*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
This event is offered virtually. Please click here to join via Zoom.
“Translational Research in Interventional Radiology: Multimodality Stroke Treatment and Locoregional Chemotherapy”
Steven Hetts, M.D.
Professor, Radiology
UCSF School of Medicine
ABSTRACT
Image-guided therapies are rapidly becoming the standard of care for several diseases. Different modalities of imaging provide different types of information essential to treating physicians. Medical devices designed for minimally-invasive image-guided interventions offer excellent opportunities for engineering innovation and partnership with clinicians. Stroke and cancer will be used as illustrative cases in point.
BIOGRAPHY
Steven Hetts, MD is Chief of Interventional Neuroradiology at the UCSF Mission Bay Hospitals, where he provides cutting-edge, minimally invasive endovascular surgical therapy for children and adults with stroke, cerebrovascular disease and tumors. Dr. Hetts is also Co-Director of the UCSF Hereditary Hemorrhagic Telangiectasia Center of Excellence where he cares for patients with vascular malformations of the brain and other organs. In 2017, Dr. Hetts was honored with an Exceptional Physician Award from UCSF Health for his clinical work. As Co-Director of the NIH-funded Interventional Radiology Research Laboratory, Dr. Hetts develops novel medical devices and techniques for the treatment of stroke, tumors, vascular malformations, and other conditions accessible through the blood vessels. He has published over 250 peer-reviewed articles and book chapters, has lectured on interventional neuroradiology clinical practice and research on six continents, and has been named a Distinguished Investigator by the national Academy of Radiology and Biomedical Imaging Research. In 2017, Dr. Hetts received an “I Am A UC Entrepreneur” award for ChemoFilter, a device to reduce the toxicity of chemotherapy that was developed in the UCSF Interventional Radiology Research Lab. Dr. Hetts earned his MD from Harvard Medical School and his bachelor’s degree from Harvard College. He completed a medical internship at Stanford and diagnostic radiology residency, diagnostic neuroradiology fellowship, and interventional neuroradiology fellowship at UCSF, where he joined the faculty in 2008.
